With the increase in volume and complexity of drug safety data, artificial intelligence is transforming the functioning of pharmacovigilance systems globally. By enabling quicker detection of adverse events and enhancing regulatory compliance alongside patient safety, AI and automation are shifting drug safety from a reactive approach to a proactive one. This change indicates a wider transformation in healthcare management, where advanced systems facilitate quicker decisions, lower risks, and enhance public confidence in medications.